Roll-out of community voluntary male circumcision is linked to reduced HIV infection levels

September 03, 2013

Roll-out of voluntary male circumcision services into the community of Orange Farm, South Africa is linked to substantial reductions in HIV infection levels, according to a study published in this week's PLOS Medicine. The study, (ANRS-12126), conducted by Bertran Auvert and colleagues from the University of Versailles (France), also reported that substantial uptake of voluntary male circumcision in one community was not linked to changes in sexual behavior that might affect HIV infection rates.

In this study, Bertran Auvert and colleagues estimated HIV infection levels in men associated with the implementation of the Bophelo Pele project, a community-based campaign against HIV that was initiated in 2008 and that includes free voluntary male circumcision services. Approximately 18,000 circumcision procedures on adult men were performed between 2008 and 2010.

Using information from surveys, the researchers observed that 12% of the men surveyed had been circumcised before the implementation of the Bophelo Pele project whereas in the follow-up survey, the overall rate of circumcision increased to 53% of the men surveyed. The overall HIV rate at follow-up was 12% and the researchers estimated that without the circumcision procedures performed during the Bophelo Pele project, the rate of HIV among men living in this community would have been 15% in 2011. The findings suggest that circumcision was also linked to a reduced number of new HIV infections but the methods used in this study cannot prove cause and effect. However, importantly, there was no evidence of a link between circumcision status and risky sexual behavior.

The authors say: "This study suggests that the roll-out of adult [voluntary medical male circumcision] is associated with a reduction in HIV in a sub-Saharan community where [male circumcision] is not a social norm."

They continue: " The main implication of this study is that the current roll-out of adult [voluntary medical male circumcision], endorsed by UNAIDS and WHO, and supported by international agencies such as PEPFAR, the Global Fund, and by donors like the Bill and Melinda gates Foundation, should be accelerated."
-end-
Funding: Funding and sponsorship for this study was provided by the French Agency for AIDS and Viral Hepatitis Research (ANRS; grant 12126). Additional funding was provided by the Bill and Melinda Gates Foundation (BMGF; USA; OPP1021324), and PEPFAR (USA) through USAID. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Competing Interests: GP has received travel grants, consultancy fees, honoraria, or study grants from various pharmaceutical companies including Abbott, Boehringer-Ingelheim, Bristol-Myers Squibb, Gilead Sciences, Janssen, Merck, Roche, Splicos, and ViiV Healthcare. GP is a member of different committees of the French National Agency for Research on AIDS and Viral Hepatitis (HIV Pharmacology, HIV Resistance, Therapeutic Strategy on HIV and Viral Hepatitis). All other authors have declared that no competing interests exist.

Citation: Auvert B, Taljaard D, Rech D, Lissouba P, Singh B, et al. (2013) Association of the ANRS-12126 Male Circumcision Project with HIV Levels among Men in a South African Township: Evaluation of Effectiveness using Cross-sectional Surveys. PLoS Med 10(9): e1001509. doi:10.1371/journal.pmed.1001509

IN YOUR COVERAGE PLEASE USE THIS URL TO PROVIDE ACCESS TO THE FREELY AVAILABLE PAPER:

http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.1001509

Contact:

Bertran Auvert
University of Versailles - INSERM
FRANCE
+33 6 03135159
bertran.auvert@uvsq.fr

PLOS

Related HIV Articles from Brightsurf:

BEAT-HIV Delaney collaboratory issues recommendations measuring persistent HIV reservoirs
Spearheaded by Wistar scientists, top worldwide HIV researchers from the BEAT-HIV Martin Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy (BEAT-HIV Collaboratory) compiled the first comprehensive set of recommendations on how to best measure the size of persistent HIV reservoirs during cure-directed clinical studies.

The Lancet HIV: Study suggests a second patient has been cured of HIV
A study of the second HIV patient to undergo successful stem cell transplantation from donors with a HIV-resistant gene, finds that there was no active viral infection in the patient's blood 30 months after they stopped anti-retroviral therapy, according to a case report published in The Lancet HIV journal and presented at CROI (Conference on Retroviruses and Opportunistic Infections).

Children with HIV score below HIV-negative peers in cognitive, motor function tests
Children who acquired HIV in utero or during birth or breastfeeding did not perform as well as their peers who do not have HIV on tests measuring cognitive ability, motor function and attention, according to a report published online today in Clinical Infectious Diseases.

Efforts to end the HIV epidemic must not ignore people already living with HIV
Efforts to prevent new HIV transmissions in the US must be accompanied by addressing HIV-associated comorbidities to improve the health of people already living with HIV, NIH experts assert in the third of a series of JAMA commentaries.

The Lancet HIV: Severe anti-LGBT legislations associated with lower testing and awareness of HIV in African countries
This first systematic review to investigate HIV testing, treatment and viral suppression in men who have sex with men in Africa finds that among the most recent studies (conducted after 2011) only half of men have been tested for HIV in the past 12 months.

The Lancet HIV: Tenfold increase in number of adolescents on HIV treatment in South Africa since 2010, but many still untreated
A new study of more than 700,000 one to 19-year olds being treated for HIV infection suggests a ten-fold increase in the number of adolescents aged 15 to 19 receiving HIV treatment in South Africa, according to results published in The Lancet HIV journal.

Starting HIV treatment in ERs may be key to ending HIV spread worldwide
In a follow-up study conducted in South Africa, Johns Hopkins Medicine researchers say they have evidence that hospital emergency departments (EDs) worldwide may be key strategic settings for curbing the spread of HIV infections in hard-to-reach populations if the EDs jump-start treatment and case management as well as diagnosis of the disease.

NIH HIV experts prioritize research to achieve sustained ART-free HIV remission
Achieving sustained remission of HIV without life-long antiretroviral therapy (ART) is a top HIV research priority, according to a new commentary in JAMA by experts at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

The Lancet HIV: PrEP implementation is associated with a rapid decline in new HIV infections
Study from Australia is the first to evaluate a population-level roll-out of pre-exposure prophylaxis (PrEP) in men who have sex with men.

Researchers date 'hibernating' HIV strains, advancing BC's leadership in HIV cure research
Researchers have developed a novel way for dating 'hibernating' HIV strains, in an advancement for HIV cure research.

Read More: HIV News and HIV Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.